Hiya, no, this is commercially confidential so I doubt we will get an exact figure anytime. Once the product revenue details start coming out and we know how much the local pricing is + margins, we would be able to guesstimate the profit component.
certainly over time - eg Divoc sells those 77k + upto 1m devices further -, the margin + total revenue will show in Qtrlies.
Will be interesting to compare the $ for Access Bio North America deal (similar profit sharing agreement) against Divoc deal (which uses NG Biotech test) once they get going.
